Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excimer Laser and Acitretin for Palmoplantar Psoriasis
NCT02181790Phase 4Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jun 2014
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
Phase 4, open-label trial (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoints: Psoriasis Area and Severity Index at 12 weeks and Dermatology Life Quality Index at 8 weeks. Started Jun 2014; status: terminated.
Beyond the preview
Go deeper on NCT02181790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02181790.